BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
General Description:
The Submission Strategy Lead (SSL) serves as the regional submission strategy, governance, and submission risk management lead for multi-country clinical studies conducted across the EMEA region providing regulatory intelligence related to clinical trial submissions and ethics requirements throughout the study lifecycle.
The SSL acts as subject matter expert in clinical trial submission requirements and operational regulatory implementation, with extensive knowledge of the EU Clinical Trial Regulation (CTR), CTIS processes, ethics committee requirements, and country-specific clinical trial submission frameworks across the EMEA region.
The SSL plays a critical role in submission governance by driving strategic submission decisions, building submission plans and timelines, monitoring critical path activities, proactively identifying and escalating risks, issues, delays, and trends across the study portfolio, analyzing RFIs and performance metrics, and leading continuous improvement initiatives to enhance submission quality, predictability, and speed.
Key responsibilities also include amendment impact assessment, cross-country risk management, regulatory intelligence, and escalation management. The SSL acts as the primary regional interface between Regional and Country teams for submission-related strategy, governance, and operational regulatory alignment, facilitating effective communication and decision-making across stakeholders.
In addition, the SSL contributes to submission activities portfolio-level oversight, continuous process improvement, standards development, quality governance initiatives, and submission innovation efforts aimed at enhancing submission effectiveness and accelerating study start-up across the EMEA region.
Success in this role requires strong strategic thinking, stakeholder management, influencing, communication, and leadership skills, as well as a thorough understanding of ICH-GCP, EU CTR, ethics committee processes, country-specific clinical trial requirements, and internal quality standards.
Essential Functions of the job:
Clinical Trial Submission Strategy & Regulatory Intelligence
Submission Governance & Risk Management
Amendment Impact Assessment & Implementation Governance
Core Package Quality & Cross-Country Alignment
Regional & Country Alignment
Portfolio Oversight, Quality & Continuous Improvement
Education Required:
*Exceptions may be made to candidates with appropriate Clinical Operations or Regulatory Affairs experience.
Computer Skills:
Good to Intermediate knowledge of Microsoft Word, Excel, PowerPoint, SharePoint, Microsoft Teams, and Outlook.
Demonstrates working knowledge of Clinical Trial Management Systems.
Other Qualifications:
• Fluent in written and verbal English
• Strong interpersonal skills, can-do attitude, and problem-solving skills.
• Able to multi-task and meet compressed timelines.
Travel
Limited to no business travel expected.
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.

Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible.
To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.